The Hippo pathway and its effectors, YAP and TAZ, are key regulators of HSC activation and hepatic fibrosis: we and others have shown that YAP drives hepatic stellate cell (HSC) activation, and YAP inhibition leads to HSC inactivation and fibrosis regression5–10. This evidence concerns the gene YAP1 and Hepatic fibrosis.